Cargando…
Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson’s Disease
Increasing evidence is supporting the hypothesis of α-synuclein pathology spreading from the gut to the brain although the exact etiology of Parkinson’s disease (PD) is unknown. Furthermore, it has been proposed that inflammation, via the gastrointestinal tract, potentially through infections, may c...
Autores principales: | van Kessel, Sebastiaan P., El Aidy, Sahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839483/ https://www.ncbi.nlm.nih.gov/pubmed/31609701 http://dx.doi.org/10.3233/JPD-191780 |
Ejemplares similares
-
Parkinson’s Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats
por: van Kessel, Sebastiaan P., et al.
Publicado: (2022) -
Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019) -
Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2021) -
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2019) -
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2020)